Quick Takeaways
- This page summarizes Christopher B. Ehrlich's Form 4 filing for CERO THERAPEUTICS HOLDINGS, INC. (CERO).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 09 Jan 2026, 16:30.
Christopher B. Ehrlich - 07 Jan 2026 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)
- Signature
- /s/ Andrew Kucharchuk, Attorney-in-Fact
- Issuer symbol
- CERO
- Transactions as of
- 07 Jan 2026
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 09 Jan 2026, 16:30:15 UTC
- Previous filing
- 02 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher B. Ehrlich filed Form 4 for CERO THERAPEUTICS HOLDINGS, INC. (CERO) on 09 Jan 2026."
What Changed
- Previous filing in this sequence was filed on 02 Jun 2025.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ehrlich Christopher B | Chairman and CEO, Director | CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO | /s/ Andrew Kucharchuk, Attorney-in-Fact | 09 Jan 2026 | 0001293973 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CERO | Stock Option (Right to Buy) | Award | $0 | +4,530,997 | $0.000000 | 4,530,997 | 07 Jan 2026 | Common Stock | 4,530,997 | $0.0550 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.